Sun Pharma Fact Sheet, Sun Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Fact Sheet    (SUNP)


Investing in EV Stocks: Do this First


Here is the latest financial fact sheet of Sun Pharma. For more details, see the Sun Pharma quarterly results and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUN PHARMA Price History

Price Rs 807.7
Mkt Cap Rs m 1,937,823
Vol '000 64.3
P/E X 31.6
P/CF X 44.4
EPS (TTM) Rs 25.5
% ch % -2.1
No. of shares m 2,399.34
% ch week % -0.9
% ch 1-mth % 5.9
% ch 12-mth % 71.6
52 week H/L Rs 850.0/452.6
(As on Oct 28, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
SUN PHARMA EQUITY SHARE DATA
High Rs842701679484654 
Low Rs572433375315339 
Sales per share (Unadj.) Rs129.4109.8121.1136.9139.6 
Earnings per share (Unadj.) Rs32.710.713.417.49.5 
Diluted earnings per shareRs32.710.713.417.49.5 
Cash flow per share (Unadj.) Rs37.917.020.726.018.2 
Dividends per share (Unadj.) Rs3.502.002.754.007.50 
Adj. dividends per shareRs3.502.002.754.007.50 
Avg Dividend yield %0.50.40.51.01.5 
Book value per share (Unadj.) Rs152.7159.7172.6188.7193.6 
Adj. book value per shareRs152.7159.7172.6188.7193.6 
Shares outstanding (eoy) m2,399.262,399.322,399.342,399.342,399.34 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x5.55.24.42.93.6 
Avg P/E ratio x21.753.039.422.952.1 
P/CF ratio (eoy) x18.633.425.515.427.3 
Price / Book Value ratio x4.63.53.12.12.6 
Dividend payout %10.718.720.622.978.8 
Avg Mkt Cap Rs m1,696,8771,360,0561,264,689958,8941,190,430 
No. of employees `000NANANANANA 
Total wages/salary Rs m49,02353,67159,67163,62468,622 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
SUN PHARMA INCOME DATA
Net Sales Rs m310,378263,416290,659328,375334,981 
Other income Rs m10,3029,12110,5946,5168,592 
Total revenues Rs m320,680272,537301,253334,891343,573 
Gross profit Rs m96,82245,84350,59367,13541,616 
Depreciation Rs m12,64814,99817,53320,52820,800 
Interest Rs m3,9985,1765,5533,0271,414 
Profit before tax Rs m90,47934,79038,10250,09627,994 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m12,1169,1106,0098,2285,147 
Profit after tax Rs m78,36325,67932,09341,86822,847 
Gross profit margin %31.217.417.420.412.4 
Effective tax rate %13.426.215.816.418.4 
Net profit margin %25.29.711.012.86.8 
SUN PHARMA BALANCE SHEET DATA
Current assets Rs m329,537316,359310,692316,542304,421 
Current liabilities Rs m178,870198,643173,396157,064161,456 
Net working cap to sales %48.544.747.248.642.7 
Current ratio x1.81.61.82.01.9 
Inventory Days Days67184148158149 
Debtors Days Days8510811210599 
Net fixed assets Rs m259,638304,731310,698334,230336,682 
Share capital Rs m2,3992,3992,3992,3992,399 
"Free" reserves Rs m363,971380,742411,691450,245462,229 
Net worth Rs m366,370383,141414,091452,645464,628 
Long term debt Rs m14,36117,72115,22620,2898,981 
Total assets Rs m589,174621,090621,389650,772641,103 
Interest coverage x23.67.77.917.520.8 
Debt to equity ratio x00000 
Sales to assets ratio x0.50.40.50.50.5 
Return on assets %14.05.06.16.93.8 
Return on equity %21.46.77.89.24.9 
Return on capital %24.810.010.211.26.2 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m44,11851,40366,02574,21984,493 
Fx outflow Rs m24,48432,23338,61027,96430,334 
Net fx Rs m19,63419,17027,41546,25554,159 
SUN PHARMA CASH FLOW
From Operations Rs m 70,822 39,072 21,965 65,548 61,704 
From Investments Rs m -42,216 -33,708 -6,813 -25,888 5,362 
From Financial Activity Rs m -22,854 -15,393 -27,305 -57,151 -59,805 
Net Cashflow Rs m 6,107 -7,359 -8,442 -13,857 5,964 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 54.5%
Institution 33.8%
Non-Institution 11.7%
Total 100.0%
Free Float 45.5%
Pledged promoter holdings 6.5%
 

Company Information

REGD OFF Sun Pharma Advanced Research Centre (S P A R C), Tandalja, Vadodara - 390020
E-MAIL secretarial@sunpharma.com WEB www.sunpharma.com
TEL 0265- 5515500 / 5515600 / 5515700 FAX 0265- 2354897
SECTOR PHARMACEUTICALS GROUP Sun Pharmaceutical Group
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
AUDITOR Deloitte Haskins & Sells
CHM: Israel Makov COMP SEC: Sunil R. Ajmera YEAR OF INC: 1993 BSE CODE: 524715 FV (Rs): 1 DIV YIELD (%): 0.9

Read: SUN PHARMA 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   ALEMBIC  VIVIMED LABS  REKVINA LABS  BALAXI PHARMA  VIJAYA DIAGNOSTIC  

Compare SUN PHARMA With:   ALEMBIC  VIVIMED LABS  REKVINA LABS  BALAXI PHARMA  VIJAYA DIAGNOSTIC  




Today's Market

4 Reasons Why Sensex Plunged 1,159 Points Today(Closing)

Indian share markets witnessed heavy selling today and ended deep in the red.

Views on news

SUN PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 22, 2021 | Updated on Oct 22, 2021

Here's an analysis of the annual report of SUN PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Sun Pharma's Stock Falls 4% After Its March Quarter Results (Views On News)

May 28, 2021

In the past three months, the stock has outperformed the market by gaining nearly 20%. Can it go higher?

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Tata Group Stocks are on Fire: Which one Should You Buy? (Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

India's Big PSU Selloff: Watch Out for these Top Stocks (Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

Up 31,500% in a Year! This Packaging Company Sheds its Penny Stock Status (Views On News)

Oct 18, 2021

What's driving the relentless rally in this packaging company?

Insider Alert! Promoters are Increasing their Stakes in these 5 Companies (Views On News)

Oct 19, 2021

Promoters of many small and mid-cap companies are raising their stakes since the last few quarters.

The One Company Riding the Auto Revolution Beyond EVs (Profit Hunter)

Oct 22, 2021

It's not just about batteries taking over the internal combustion engine. Bigger disruptive forces are coming along with electrification.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - ADCOCK INGRAM COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS